Multiparametric 3T MR approach to the assessment of cerebral gliomas: Tumor extent and malignancy

Neuroradiology

Volumn 48, Issue 9, 2006, Pages 622-631

  Costanzo, Alfonso ^a   Scarabino, Tommaso ^b   Trojsi, Francesca ^c   Giannatempo, Giuseppe M ^b   Popolizio, Teresa ^b   Catapano, Domenico ^c   Bonavita, Simona ^c   Maggialetti, Nicola ^d   Tosetti, Michela ^e   Salvolini, Ugo ^f   d'Angelo, Vincenzo A ^b   Tedeschi, Giocchino ^c  

^a UNIVERSITY OF MOLISE   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^f OSPEDALI RIUNITI   (Italy)

Author keywords

Brain tumor; Cerebral blood volume; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; GADOLINIUM; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; BRAIN EDEMA; BRAIN METABOLISM; BRAIN SURGERY; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISCRIMINANT ANALYSIS; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BRAIN NEOPLASMS; CHOLINE; CONTRAST MEDIA; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; LACTIC ACID; LIPIDS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 33748487170     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-006-0102-3     Document Type: Article

References (39)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y (2003) Primary brain tumours in adults. Lancet 361: 323-331
2. Grant R (2004) Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry 75 [Suppl 2]: II18-II23
3. Schneider JP, Trantakis C, Rubach M, et al (2005) Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme - a quantitative radiological analysis. Neuroradiology 47: 489-500
4. Law M, Yang S, Wang H, et al (2003) Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24: 1989-1998
5. Croteau D, Scarpace L, Hearshen D, et al (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49: 823-829
6. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16: 229-237
7. Preul MC, Caramanos Z, Leblanc R, Villemure JG, Arnold DL (1998) Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 11: 192-200
8. Burtscher IM, Skagerberg G, Geijer B, Englund E, Ståhlberg F, Holtås S (2000) Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 21: 84-93
9. Dowling C, Bollen AW, Noworolski SM, et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22: 604-612
10. Pirzkall A, Mcknight TR, Graves EE, et al (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50: 915-928
11. Rees J (2003) Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16: 643-650
12. Sugahara T, Korogi Y, Kochi M, et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9: 53-60
13. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J (1994) MR imaging of high-grade cerebral gliomas: Value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162: 671-677
14. Brunberg JA, Chenevert TL, McKeever PE, et al (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16: 361-371
15. Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F (1997) MR diffusion imaging of human intracranial tumours. Neuroradiology 39: 483-489
16. Yamasaki F, Kurisu K, Satoh K, et al (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235: 985-991
17. Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 57: 219-225
18. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223: 11-29
19. Lam WWM, Chan KW, Wong WL, Poon WS, Metreweli C (2001) Pre-operative grading of intracranial glioma. Acta Radiol 42: 548-554
20. Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu X-P, Li K-L (2002) Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: Comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23: 7-14
21. Preul C, Kühn B, Lang EW, Mehdorn M, Heller M, Link J (2003) Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol 48: 244-251
22. Law M, Yang S, Babb JS, et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25: 746-755
23. Muti M, Aprile I, Principi M, et al (2002) Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas. Magn Reson Imaging 20: 635-641
24. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222: 715-721
25. Tzika AA, Astrakas LG, Zarifi MK, et al (2003) Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 45: 1-10
26. Yang D, Korogi Y, Sugahara T, et al (2002) Cerebral gliomas: Prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44: 656-666
27. Chiang IC, Kuo Y-T, Lu C-Y, et al (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46: 619-627
28. Bulakbasi N, Kocaoglu M, Örs F, Tayfun C, Üçöz T (2003) Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 23: 225-233
29. Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ (2003) Magnetic resonance imaging at 3.0 Tesla: Challenges and advantages in clinical neurological imaging. Invest Radiol 38: 385-402
30. Manka C, Träber F, Gieseke J, Schild HH, Kuhl CK (2005) Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: Feasibility and contrast agent dose. Radiology 234: 869-877
31. Gupta RK, Sinha U, Cloughesy TF, Alger JR (1999) Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 41: 2-7
32. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN (1995) Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83: 682-689
33. Möller-Hartmann W, Herminghaus S, Krings T, et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44: 371-381
34. Cha S, Johnson G, Wadghiri YZ, et al (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology. Magn Reson Med 49: 848-855
35. Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: Correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81: 560-566
36. Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med 34: 835-844
37. Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34: 463-469
38. Li X, Vigneron DB, Cha S, et al (2005) Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 26: 760-769
39. Schlemmer H-P, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 22: 1316-1324